This EASL school is dedicated to chronic alcohol related liver disease, covering all aspects of the patient’s journey through the healthcare system. From alcohol’s impact on citizens in the society, to early disease detection, biomarkers used in healthcare pathways from primary to secondary care, global and specialised interventions, and new innovations to improve patient management. With the school, we aim to combat the stigma and taboo associated with the harmful effects of alcohol, and replace it with fully updated and high-quality evidence highlighting the many opportunities for improving our patient’s life and health.